Use in Ascites Management Beyond Liver Cirrhosis Frusemide and Spironolactone are also employed in the management of ascites resulting from conditions other than liver cirrhosis, such as heart failure or malignancy, providing a critical component of palliative care
Data extraction was conducted independently by LP and WH/YAD, who reviewed full texts of selected articles to extract relevant data on study design, population, interventions, outcomes, and results
Research shows that having a healthier BMI can help the body regulate estrogen levels more effectively
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
Stay consistent, be patient with yourself, and celebrate progress in all forms